Journal of Manipulative and Physiological Therapeutics
Volume 32, Issue 7 , Pages 586-591 , September 2009

Reduction in High Blood Tumor Necrosis Factor-α Levels After Manipulative Therapy in 2 Cervicogenic Headache Patients

  • Gábor Ormos, MD

      Affiliations

    • Head of Department of Rehabilitation, Hungarian National Institute for Rheumatology and Physiotherapy (HNIRP), Budapest, Hungary
    • Corresponding Author InformationSubmit requests for reprints to: Gábor Ormos, MD, Outpatient Clinic of the Hungarian National Institute for Rheumatology and Physiotherapy (HNIRP), Frankel L. 38. 1023 Budapest, Hungary
    • ,
  • J.N. Mehrishi, PhD, FRCPath

      Affiliations

    • Research Director, Cambridge Blood, Stem Cells, Spermatozoa and Opioid Research Initiatives, University of Cambridge, Cambridge, United Kingdom
    • Present address: The Cambridge Blood Cell, Stem Cells, Spermatozoa and Opioid Research Initiatives, Macfarlane Cl. 13, Impington, Cambridge CB4 9LZ, United Kingdom.
    • ,
  • Tibor Bakács, MD, DSc

      Affiliations

    • Consultant, Department of Probability, Alfred Rényi Institute of Mathematics, Hungarian Academy of Science, Budapest, Hungary

Received 16 November 2008 ,Revised 16 May 2009

References 

  1. Jensen OK, Nielsen FF. The influence of sex and pre-traumatic headache on the incidence and severity of headache after head injury. Cephalalgia. 1990;10:285–293
  2. Jensen OK, Nielsen FF, Vosmar L. An open study comparing manual therapy with the use of cold packs in the treatment of post-traumatic headache. Cephalalgia. 1990;10:241–250
  3. Feldmann M, Maini SR. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev. 2008;223:7–19
  4. Beutler BA. The role of tumor necrosis factor in health and disease. J Rheumatol Suppl. 1999;57:16–21
  5. Elliott MJ, Maini RN, Feldmann M, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994;344:1105–1110
  6. Stack WA, Mann SD, Roy AJ, et al. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet. 1997;349:521–524
  7. Fekade D, Knox K, Hussein K, et al. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med. 1996;335:311–315
  8. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 1997;337:141–147
  9. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med. 2000;51:207–229
  10. Bell S, Kamm MA. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet. 2000;355:858–860
  11. Garnett WR, Yunker N. Treatment of Crohn's disease with infliximab. Am J Health Syst Pharm. 2001;58:307–316
  12. Han PD, Cohen RD. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease. Drugs. 2004;64:1767–1777
  13. Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P. Pathophysiology of disk-related sciatica. I. Evidence supporting a chemical component. Joint Bone Spine. 2006;73:151–158
  14. Ohtori S, Takahashi K, Moriya H, Myers RR. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine. 2004;29:1082–1088
  15. Sekiguchi M, Kobayashi H, Sekiguchi Y, Konno S, Kikuchi S. Sympathectomy reduces mechanical allodynia, tumor necrosis factor-alpha expression, and dorsal root ganglion apoptosis following nerve root crush injury. Spine. 2008;33:1163–1169
  16. Sjaastad O, Saunte C, Hovdahl H, Breivik H, Gronbaek E. “Cervicogenic” headache. An hypothesis. Cephalalgia. 1983;3:249–256
  17. Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. The Cervicogenic Headache International Study Group. Headache. 1998;38:442–445
  18. Goupille P, Mulleman D, Valat JP. Radiculopathy associated with disc herniation. Ann Rheum Dis. 2006;65:141–143
  19. Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine. 2001;26:863–869
  20. Fredriksen TA. Cervicogenic headache: invasive procedures. Cephalalgia. 2008;28(Suppl 1):39–40
  21. Fredriksen TA, Sjaastad O. Cervicogenic headache: current concepts of pathogenesis related to anatomical structure. Clin Exp Rheumatol. 2000;18(2 Suppl 19):S16–S18
  22. Ahn Y, Lee SH, Chung SE, Park HS, Shin SW. Percutaneous endoscopic cervical discectomy for discogenic cervical headache due to soft disc herniation. Neuroradiology. 2005;47:924–930
  23. Jansen J, Sjaastad O. Cervicogenic headache: long-term prognosis after neck surgery. Acta Neurol Scand. 2007;115:185–191
  24. Martelletti P. Proinflammatory pathways in cervicogenic headache. Clin Exp Rheumatol. 2000;18(2 Suppl 19):S33–S38
  25. Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache. 2007;47:1050–1055
  26. Perini F, D'Andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005;45:926–931

PII: S0161-4754(09)00188-2

doi: 10.1016/j.jmpt.2009.08.006

Journal of Manipulative and Physiological Therapeutics
Volume 32, Issue 7 , Pages 586-591 , September 2009

Article Tools

* Image Usage & Resolution